Clinical Trials Logo

Colorectal Liver Metastases clinical trials

View clinical trials related to Colorectal Liver Metastases.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT01318447 Terminated - Clinical trials for Colorectal Liver Metastases

CyberKnife® for Hepatic Metastases From Colorectal Cancer

Start date: January 2011
Phase: Phase 2
Study type: Interventional

This prospective, multicenter study is intended to establish the efficacy and toxicity of treating unresectable colorectal liver metastases with accurately administered radiation using the CyberKnife stereotactic radiosurgery system.

NCT ID: NCT00508872 Terminated - Clinical trials for Colorectal Liver Metastases

Folfox-B Study for Patients With Colorectal Liver Metastases

Start date: November 2005
Phase: Phase 2
Study type: Interventional

Objective: - To evaluate the efficacy of the use of the combination of oxaliplatin, 5-fluorouracil, leucovorin and bevacizumab (FOLFOX-B) in patients with unresectable colorectal liver metastases, with the objective to downstage hepatic disease and enable complete resection of residual disease. Primary Objective: - To evaluate the resection rate in patients with initially unresectable hepatic colorectal metastases downstaged with FOLFOX-B. Complete resection of all liver lesions is the goal. Secondary Objectives: - To evaluate the probability of complete response, partial response or stable disease. - To evaluate the proportion of patients who are resected, and the proportion of patients achieving an R0 resection (among those receiving surgery). - To correlate survival with downstaging and resection based on metastatic colorectal prognostic score. - To evaluate the disease-free survival and overall survival. - To evaluate the positron emission tomography response rate. - To explore correlations of clinical response with telomerase and hTERT expression.